Dawei Chen, MD, PhD

Shandong Cancer Hospital and Institute, Shandong First Medical University

Jinan, Shandong

Dawei Chen MD, PhD

Department of Shandong Provincial Key Laboratory of Precision Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, People's Republic of China

Dr. Chen is a Doctor of Radiation Oncology, Distinguished Associate Researcher, Associate Professor, and PhD Supervisor at Shandong University. He serves as Deputy Director of the Shandong Cancer Hospital Radiation-Immunology Laboratory, holds the Shandong Provincial Excellent Young Scientist Fund, and leads a National Natural Science Foundation of China (NSFC) General Program. A Visiting Scholar in the Department of Radiation Oncology at MD Anderson Cancer Center, he was named one of CSCO's “35 Under 35 Most Promising Young Oncologists” in 2020. Dr. Li has published multiple SCI papers as first or corresponding author, and currently sits on the Immune-Radiotherapy Group of the Chinese Society of Radiation Oncology, the CSCO Non-Small Cell Lung Cancer Committee, and the Standing Committee of the Tumor Immunology & Immunotherapy Society of the Shandong Anti-Cancer Association.

Disclosures:

Employment: none
Compensation: none
Ownership: none
Leadership: none

Presentations

Sep 28

2333 - Concurrent Immunotherapy Improves Progression-Free Survival but Increases Toxicity in Unresectable Stage III NSCLC

Hall F

04:45pm - 06:00pm PT

Sep 29

3038 - Immune Checkpoint Inhibitors Administered Prior to Chemoradiotherapy Increase Radiation-Induced Pneumonitis Risk in Stage III Unresectable NSCLC

Hall F

05:00pm - 06:00pm PT